Pression, founded with the mission to enhance body-wide blood flow using smart compression technology, focuses on developing medical devices primarily for heart failure and refractory angina patients. Their flagship product, the Wave PRO, offers non-invasive external counterpulsation therapy designed to improve circulation and alleviate symptoms of debilitating chest pain. By targeting coronary artery disease patients who have exhausted other medical treatments, Pression aims to fill a critical gap in cardiovascular care.

Notable figures associated with Pression include leading cardiologists and medical device experts who contribute to the company's innovative approach. The firm has secured investments from prominent healthcare venture capitalists, underscoring its potential impact in the medical field. Key achievements include the development and patenting of their smart compression system, which has shown promise in clinical settings. Pression's technology not only improves patient outcomes but also aims to reduce overall healthcare costs by providing an effective alternative to more invasive procedures.